Publication:
Inhibitory Effect of Selenium Nanoparticles on the Biofilm Formation of Multidrug-Resistant Acinetobacter Baumannii

dc.contributor.authorŠmitran, Aleksandra (55865631000)
dc.contributor.authorLuković, Bojana (57189443662)
dc.contributor.authorBožić, Ljiljana (57202649173)
dc.contributor.authorGolić, Bojan (57194492291)
dc.contributor.authorGajić, Ina (55428924700)
dc.date.accessioned2025-06-12T11:42:48Z
dc.date.available2025-06-12T11:42:48Z
dc.date.issued2024
dc.description.abstractBackground/Aim: Treatment of infections caused by biofilm-producing multidrug-resistant (MDR) pathogens represents a huge global problem due to primary antimicrobial multi-resistance enhanced by reduced penetration of antibiotics in the biofilm-embedded bacteria. The aim of this study was to determine the capacity of biofilm production among MDR Acine-tobacter baumannii (A. baumannii) isolates obtained from different clinical specimens and to evaluate the inhibitory effect of selenium nanoparticles (SeNPs) coated with cationic polymer cetyltrimethylammonium bromide (CTAB) on the biofilm formation. Methods: Antimicrobial effect of antibiotics (meropenem, imipenem, gentamicin, amikacin, ciprofloxacin, levofloxacin and trimethoprim-sulfa-methoxazole) was determined by disk-diffusion assay, while sensitivity to colistin was determined with E test. All 60 isolates were tested on biofilm production in microtiter plates with crystal violet dye. Minimal biofilm inhib-itory concentration (MBIC) of SeNPs was tested in order to prevent biofilm formation in microtiter plates. Results: All tested clinical isolates were classified as MDR (n = 60) and extensively drug-resistant (XDR, n = 60). Out of the total 60 isolates, 55 isolates (92 %) showed the ability for biofilm formation, with the majority of them classified as strong (42 %) and moderate (42 %) biofilm produc-ers. MBIC values of SeNPs for 55 biofilm-producing isolates ranged from 0.07 to 1.25 mg/mL. Strong biofilm producers had statistically higher MBIC (0.15 mg/mL) in correlation to other biofilm-producing isolates (0.07 mg/ mL). There was no correlation between invasiveness of isolates with biofilm production and MBIC values. Conclusion: Presented results are very promising and interesting espe-cially in nanotechnology and medical fields, while SeNPs with the addition of cationic surfactant inhibit biofilm formation of MDR A. baumannii clinical isolates. © 2024, Faculty of Medicine, University of Banja Luka. All rights reserved.
dc.identifier.urihttps://doi.org/10.5937/scriptamed55-49892
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85199598106&doi=10.5937%2fscriptamed55-49892&partnerID=40&md5=110bf1ab99af7583f71b6e395ecd40d4
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1070
dc.subjectAcinetobacter baumannii
dc.subjectBiofilm
dc.subjectSelenium nanoparticles
dc.titleInhibitory Effect of Selenium Nanoparticles on the Biofilm Formation of Multidrug-Resistant Acinetobacter Baumannii
dspace.entity.typePublication

Files